Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022;49:1682–99.

Article  PubMed  PubMed Central  Google Scholar 

Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41:1673–81.

PubMed  Google Scholar 

Garlipp B, De Baere T, Damm R, Irmscher R, van Buskirk M, Stübs P, et al. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology. 2014;59:1864–73.

Article  PubMed  Google Scholar 

Orcutt ST, Abuodeh Y, Naghavi A, Frakes J, Hoffe S, Kis B, et al. Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors. Surgery. 2018;163:1020–7.

Article  PubMed  Google Scholar 

Theysohn JM, Demircioglu A, Kleditzsch M, Ludwig JM, Weber M, Umutlu L, et al. Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation. Sci Rep. 2022;12:20718.

Article  PubMed  PubMed Central  Google Scholar 

Coskun N, Yildirim A, Yuksel AO, Canyigit M, Ozdemir E. The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver. Nucl Med Mol Imaging. 2022;56:291–8.

Article  PubMed  PubMed Central  Google Scholar 

Lu Z, Polan DF, Wei L, Aryal MP, Fitzpatrick K, Wang C, et al. PET/CT-based absorbed dose maps in 90Y selective ınternal radiation therapy correlate with spatial changes in liver function derived from dynamic MRI. J Nucl Med. 2024;65:1224–30.

Article  PubMed  Google Scholar 

Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J, et al. EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys. 2021;8:1–44.

Article  Google Scholar 

Takahashi A, Himuro K, Baba S, Yamashita Y, Sasaki M. Comparison of TOF-PET and Bremsstrahlung SPECT Images of Yttrium-90: A Monte Carlo Simulation Study. Asia Ocean J Nucl Med Biol. 2018;6:24–31.

PubMed  PubMed Central  Google Scholar 

Elschot M, Vermolen BJ, Lam MGEH, de Keizer B, van den Bosch MAAJ, de Jong HWAM. Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS One. 2013;8:e55742.

Article  PubMed  PubMed Central  Google Scholar 

Mikell JK, Kaza RK, Roberson PL, Younge KC, Srinivasa RN, Majdalany BS, et al. Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization. EJNMMI Phys. 2018;5:1–17.

Article  Google Scholar 

Romanò C, Mazzaglia S, Maccauro M, Spreafico C, Gabutti A, Maffi G, et al. Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods. Cancers (Basel). 2022;14:959.

Article  PubMed  Google Scholar 

Knešaurek K, Tuli A, Kim E, Heiba S, Kostakoglu L. Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres. EJNMMI Phys. 2018;5:1–10.

Article  Google Scholar 

Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, et al. PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response. Cardiovasc Intervent Radiol. 2016;39:855–64.

Article  PubMed  Google Scholar 

Alsultan AA, van Roekel C, Barentsz MW, Smits MLJ, Kunnen B, Koopman M, et al. Dose-Response and Dose-Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer. J Nucl Med. 2021;62:1616–23.

Article  PubMed  PubMed Central  Google Scholar 

Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res. 2013;3:1–27.

Google Scholar 

Gnesin S, Canetti L, Adib S, Cherbuin N, Monteiro MS, Bize P, et al. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison. J Nucl Med. 2016;57:1672–8.

Article  PubMed  Google Scholar 

Jadoul A, Bernard C, Lovinfosse P, Gérard L, Lilet H, Cornet O, et al. Comparative dosimetry between 99mTc-MAA SPECT/CT and 90Y PET/CT in primary and metastatic liver tumors. Eur J Nucl Med Mol Imaging. 2020;47:828–37.

Article  PubMed  Google Scholar 

Richetta E, Pasquino M, Poli M, Cutaia C, Valero C, Tabone M, et al. PET-CT post therapy dosimetry in radioembolization with resin 90Y microspheres: Comparison with pre-treatment SPECT-CT 99mTc-MAA results. Phys Med. 2019;64:16–23.

Article  PubMed  Google Scholar 

Simplicit90y Dosimetry Planning Software | Read more [Internet].

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323–41.

Article  PubMed  PubMed Central  Google Scholar 

3D Slicer image computing platform | 3D Slicer [Internet].

Dixon M, Cruz J, Sarwani N, Gusani N. The Future Liver Remnant : Definition, Evaluation, and Management. Am Surg. 2021;87:276–86.

Article  PubMed  Google Scholar 

Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in western adults. Liver Transpl. 2002;8:233–40.

Article  PubMed  Google Scholar 

Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94.

Article  PubMed  Google Scholar 

Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant. J Am Coll Surg. 2013;216:201.

Article  PubMed  Google Scholar 

Grisanti F, Prieto E, Bastidas JF, Sancho L, Rodrigo P, Beorlegui C, et al. 3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization. Eur J Nucl Med Mol Imaging. 2021;48:3048–57.

Article  PubMed  Google Scholar 

Mercolli L, Zeimpekis K, Prenosil GA, Sari H, Rathke HG, Rominger A, et al. Phantom study for 90Y liver radioembolization dosimetry with a long axial field-of-view PET/CT. Phys Med. 2024;118:103296.

Article  PubMed  Google Scholar 

Costa G, Spencer B, Omidvari N, Foster C, Rusnak M, Hunt H, et al. Radioembolization Dosimetry with Total-Body 90Y PET. J Nucl Med. 2022;63:986–94.

Article  Google Scholar 

Labour J, Boissard P, Baudier T, Khayi F, Kryza D, Durebex PV, et al. Yttrium-90 quantitative phantom study using digital photon counting PET. EJNMMI Phys. 2021;8:1–24.

Article  Google Scholar 

Zeimpekis KG, Mercolli L, Conti M, Sari H, Rominger A, Rathke H. 90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry. Eur J Nucl Med Mol Imaging. 2024;51:2100–13.

Article  PubMed  PubMed Central  Google Scholar